What is the primary advantage of mass spectrometry in the quantification of clinical analytes?

• A. High throughput
• B. High specificity and sensitivity
• C. Low cost
• D. Non-invasive sample requirements

Answer: (B)

Mass spectrometry’s main strength in quantifying clinical analytes is its high specificity and sensitivity. By measuring the exact mass-to-charge ratio of ionized molecules and, with tandem MS, selecting specific precursor ions and confirming them with characteristic fragment ions, MS can distinguish the target analyte from closely related compounds and interferences that would mislead other methods. This precise identification enables accurate quantification even within complex biological samples and at very low concentrations, often across a wide dynamic range. While mass spectrometry can be set up for high throughput or multiplexed analysis and can work with various sample types, those advantages come from this core capability to identify and measure the analyte with exceptional selectivity and sensitivity.